(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TRATAMENTO DE CÂNCERES COM CONJUGADOS ANTICORPO-FÁRMACO (ADC) QUE SE LIGAM A PROTEÍNAS 191P4D12

Em AnáliseInvention PatentPCT · US2020061923

Application data

Number

112022009672

Type

Invention Patent

Filing

11/24/2020

Publication

08/16/2022

PCT

US2020061923

Progress at the INPI

  1. Filing11/24/20
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 11/24/2020. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 08/16/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AGENSYS, INC.

US

SEAGEN INC.

US

See this company's full portfolio

Inventors

A. M. (pessoa física)

US

E. G. (pessoa física)

US

J. D. (pessoa física)

US

L. R. (pessoa física)

US

Technical data

Priority claims

US

62/940,209 · 11/25/2019

US

62/944,890 · 12/06/2019

Abstract

TRATAMENTO DE CÂNCERES COM CONJUGADOS ANTICORPO-FÁRMACO (ADC) QUE SE LIGAM A PROTEÍNAS 191P4D12. A presente invenção refere-se a métodos para o tratamento de cânceres com conjugados anticorpo-fármaco (ADC) que ligam a proteínas 191P4D12.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

08/16/2022

RPI 2693

Alteração de dados cadastrais

#1.1

05/31/2022

RPI 2682

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.